NCT05688280 Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With CRC, NSCLC, and STS Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05686499 Building Capacity for Screening & Early Diagnosis of Colorectal Cancer Through a Comprehensive Colonoscopy Training Program in Nigeria Status RECRUITING Phase NA
NCT05677048 Feasibility Study: IGNITE-TX (Identifying Individuals for Genetic Testing & Treatment) Intervention Status ACTIVE_NOT_RECRUITING Phase NA
NCT05662527 Response to Immunotherapy in MMR-deficient Localized Colon Cancer Status COMPLETED Phase PHASE2
NCT05658263 Bacterial Intestinal Gut Modification Around Cancer Surgery (BIG MACS) Diet Status COMPLETED Phase EARLY_PHASE1
NCT05652348 Response Prediction of Hyperthermic Intraperitoneal Chemotherapy in Gastro- Intestinal Cancer Status RECRUITING Phase N/A
NCT05638048 Effect of Precise Grip Strength Training on PICC Catheter-Related Thrombosis in Cancer Patients Status COMPLETED Phase NA
NCT05546892 Short-term Outcomes of Full Bowel Preparation (MBP+OA) for Colon Cancer Resections Versus no Bowel Preparation Status UNKNOWN Phase NA
NCT05544474 Definition of Surgical Technique of Lymphadenectomy and Complete Mesocolon Excision for Radical Right Colectomy: a Delphi Consensus Status ENROLLING_BY_INVITATION Phase N/A
NCT05538195 Safety and Efficacy of CEA-targeted CAR-T for CEA-positive Advanced Malignant Solid Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT05536362 Propofol With Clonidine and Ketamine Throughout Colon Cancer Surgery Status COMPLETED Phase PHASE1
NCT05534087 Platform Study of Circulating Tumor DNA Directed Adjuvant Chemotherapy in Colon Cancer (KCSG CO22-12) Status RECRUITING Phase PHASE3
NCT05529615 Circulating Tumor DNA Guided Adjuvant Chemotherapy for Colon Cancer Status RECRUITING Phase NA
NCT05520866 PrehabPal: A Digital Tool to Help Older Adults Prepare for Cancer Surgery Status COMPLETED Phase NA
NCT05513742 A Study of CTX-009 in Adult Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT05510895 Neoadjuvant Encorafenib, Binimetinib and Cetuximab for Patients With BRAF V600E Mutated/pMMR Localized Colorectal Cancer Status COMPLETED Phase PHASE2